IPCA Laboratories Share Price Today

IPCA Labs upgrades FY27 revenue growth guidance to 14-16% on strong exports

IPCA Laboratories posted a 72% surge in Q1FY27 net profit to ₹4,019 crore on 21% revenue growth. Management upgraded FY27 revenue guidance to 14-16% and EBITDA margin to 23%, citing strong export momentum and cost efficiencies. The company plans ₹700-800 crore capex and maintains near-zero debt.

IPCA Laboratories raises FY27 EBITDA margin guidance to 23%

IPCA Laboratories raises FY27 EBITDA margin guidance to 23%. The firm plans to expand capacity, R&D, and API facilities to serve US and European markets. This reflects a strategy focused on operational efficiency and vertical integration.

Ipca Laboratories shareholders approve all resolutions at 76th AGM

Ipca Laboratories shareholders approved all six resolutions at the 76th AGM on August 13, 2026. Key outcomes included the adoption of FY26 financials, dividend declaration, and re-appointments of directors Ajit Kumar Jain, Pranay Godha, and Prashant Godha. While promoter support was unanimous, the re-appointment of Executive Director Prashant Godha faced notable dissent from public institutional holders, who voted against it at a rate of 19.25%. The cost auditor remuneration was also ratified.

Ipca Laboratories Q1 Results: Earnings call scheduled for Aug 14, 2026

Ipca Laboratories Limited has announced a Q1FY27 earnings conference call scheduled for Friday, August 14, 2026, from 15:30 hrs to 16:30 hrs IST. The call will be hosted by Dam Capital Advisors Ltd. and will feature Managing Director Mr. A K Jain and Corporate Counsel & Company Secretary Mr. Harish Kamath. The Q1FY27 financial results are set to be announced on Thursday, August 13, 2026, a day prior to the call. The announcement was filed on August 6, 2026, in compliance with SEBI (LODR) Regulations, 2015.

Ipca Laboratories Records ₹49.11 Crore Block Trade on NSE at ₹1875 Per Share

Ipca Laboratories recorded a block trade on the NSE involving approximately 261941 shares at ₹1875 per share, with a total deal value of ₹49.11 crore. Such large-scale transactions are typically executed by institutional investors outside the regular order book to minimise market impact, reflecting notable activity in the Ipca Laboratories counter.

Ipca Laboratories fixes record date for ₹6 dividend

Ipca Laboratories has established August 7, 2026, as the record date for a proposed dividend of ₹6 per share, subject to shareholder approval at the AGM on August 13, 2026. The company confirmed that the dividend will be paid on or before September 10, 2026, to eligible members. Remote e-voting is available from August 10 to August 12, 2026.